$BPTH skyrockets on Received Third U.S. Patent Grant

NASDAQ:BPTH   Bio-Path Holdings, Inc.
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology

Provides Expanded Protection to Seminal Patents Related to DNAbilize

The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.